Company / Cash & Equivalents
Molina Healthcare Cash & Equivalents History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash & Equivalents
$4.2B
FY2025
5-year range
$4.2B / $4.8B
FY2021-FY2025
Trend
-8.9%
vs FY2024
Sector context
#10 of 148
Health Care
What the data says
Among 148 Health Care companies, Molina Healthcare is in the top 7% for cash & equivalents. Cash & Equivalents has fluctuated over the past 10 years, ranging from $1.5B in FY2016 to $4.8B in FY2023.
Based on SEC 10-K filings.
$4.2B in FY2025 with a 5-year CAGR of +0.4%. Top quartile in the Health Care sector.
Declined from $4.8B to $4.2B over the past 2 years.
Health Care sector context is included.
Cash & Equivalents over time
Growth rates
- 3-Year CAGR
- -1.4%
- 5-Year CAGR
- +0.4%
- 10-Year CAGR
- -
Sector benchmark
Top 7% in Health CareTop 7% of 148This company $4.2B Sector average $1.2B
▼
+261.0% above sector average
Key checks
Key Insights
- 5-year CAGR of +0.4%, indicating consistent growth.
- In FY2025, cash & equivalents decreased 8.9% year-over-year.
- Ranks #10 out of 148 companies in the Health Care sector.
- Peak cash & equivalents was recorded in FY2023.
Company context
Key Data Points
- Altman Z-Score 3.65 (safe zone, above 2.9 threshold)
- Low earnings quality (accrual-heavy earnings)
- Strong return on equity: 21.1%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash & EquivalentsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $4.2B | -8.9% |
| FY2024 | $4.7B | -3.8% |
| FY2023 | $4.8B | +9.2% |
| FY2022 | $4.4B | +6.8% |
| FY2021 | $4.2B | +0.0% |
| FY2020 | $4.2B | +69.4% |
| FY2019 | $2.5B | -23.0% |
| FY2018 | $3.2B | +13.0% |
| FY2017 | $2.8B | +83.2% |
| FY2016 | $1.5B | -33.9% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026